Cargando…

The Emergence of Universal Immune Receptor T Cell Therapy for Cancer

Chimeric antigen receptor (CAR) T cells have shown great success in the treatment of CD19+ hematological malignancies, leading to their recent approval by the FDA as a new cancer treatment modality. However, their broad use is limited since a CAR targets a single tumor associated antigen (TAA), whic...

Descripción completa

Detalles Bibliográficos
Autores principales:	Minutolo, Nicholas G., Hollander, Erin E., Powell, Daniel J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2019
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6448045/ https://www.ncbi.nlm.nih.gov/pubmed/30984613 http://dx.doi.org/10.3389/fonc.2019.00176

Ejemplares similares

Regulatory T-Cells as an Emerging Barrier to Immune Checkpoint Inhibition in Lung Cancer
por: Principe, Daniel R., et al.
Publicado: (2021)

Incidence of Immune-Related Adverse Events with Program Death Receptor-1- and Program Death Receptor-1 Ligand-Directed Therapies in Genitourinary Cancers
por: Maughan, Benjamin L., et al.
Publicado: (2017)

Editorial: Optimizing Local Therapy for High-Risk Prostate Cancer: Evidence and Emerging Options
por: Zaorsky, Nicholas G., et al.
Publicado: (2020)

The role of targeted therapy and immune therapy in the management of non-small cell lung cancer brain metastases
por: Billena, Cole, et al.
Publicado: (2023)

Targeted Therapy for Breast Cancer Prevention
por: den Hollander, Petra, et al.
Publicado: (2013)

Emergency department use by patients who received chimeric antigen receptor T cell infusion therapy
por: Lipe, Demis N., et al.
Publicado: (2023)

Emerging Therapies in Penile Cancer
por: Alencar, Antonio Machado, et al.
Publicado: (2022)

Activity of Estrogen Receptor β Agonists in Therapy-Resistant Estrogen Receptor-Positive Breast Cancer
por: Datta, Jharna, et al.
Publicado: (2022)

Extracellular Vesicles: An Emerging Nanoplatform for Cancer Therapy
por: Ma, Yifan, et al.
Publicado: (2021)

Imaging the Rewired Metabolism in Lung Cancer in Relation to Immune Therapy
por: van Genugten, Evelien A. J., et al.
Publicado: (2022)

Immune cells and immune cell-targeted therapy in chronic pancreatitis
por: Zhang, Yu, et al.
Publicado: (2023)

Tumor Cell-Induced Platelet Aggregation as an Emerging Therapeutic Target for Cancer Therapy
por: Strasenburg, Wiktoria, et al.
Publicado: (2022)

Emerging Perspectives on Leukemia Inhibitory Factor and its Receptor in Cancer
por: Christianson, Joe, et al.
Publicado: (2021)

Targeting immune-onco-metabolism for precision cancer therapy
por: Pajai, Sakshi, et al.
Publicado: (2023)

Emerging Therapies for Stage III Non-Small Cell Lung Cancer: Stereotactic Body Radiation Therapy and Immunotherapy
por: Kumar, Sameera S., et al.
Publicado: (2017)

Editorial: Emerging strategies for cancer therapy targeting ferroptosis
por: Li, Manshan, et al.
Publicado: (2023)

Endocrine Therapy of Estrogen Receptor-Positive Breast Cancer Cells: Early Differential Effects on Stem Cell Markers
por: Leung, Euphemia Y., et al.
Publicado: (2017)

Intensity-Modulated Radiation Therapy with Stereotactic Body Radiation Therapy Boost for Unfavorable Prostate Cancer: The Georgetown University Experience
por: Mercado, Catherine, et al.
Publicado: (2016)

Effects of RANKL-Targeted Therapy in Immunity and Cancer
por: Cheng, Michael L., et al.
Publicado: (2014)

Advancing Cancer Therapy with Present and Emerging Immuno-Oncology Approaches
por: Kamta, Jeff, et al.
Publicado: (2017)

Exosome-Based Nanoplatforms: The Emerging Tools for Breast Cancer Therapy
por: Liu, Quan, et al.
Publicado: (2022)

Current and emerging anti-angiogenic therapies in gastrointestinal and hepatobiliary cancers
por: Saoudi González, Nadia, et al.
Publicado: (2022)

Emerging Landscapes of Tumor Immunity and Metabolism
por: Wu, Fan, et al.
Publicado: (2020)

Development of a novel universal immune receptor for antigen targeting: To Infinity and beyond
por: Urbanska, Katarzyna, et al.
Publicado: (2012)

Type 1 insulin-like growth factor receptor targeted therapies in pediatric cancer
por: Wagner, Michael J., et al.
Publicado: (2013)

Combination Approaches with Immune-Checkpoint Blockade in Cancer Therapy
por: Swart, Maarten, et al.
Publicado: (2016)

The Emerging Role of Targeted Therapy and Immunotherapy in the Management of Brain Metastases in Non-Small Cell Lung Cancer
por: Wong, Annick
Publicado: (2017)

HER2-Altered Non-Small Cell Lung Cancer: Biology, Clinicopathologic Features, and Emerging Therapies
por: Yu, Xin, et al.
Publicado: (2022)

The Evolution of Prostate Cancer Therapy: Targeting the Androgen Receptor
por: Aragon-Ching, Jeanny B.
Publicado: (2014)

Microbiota Manipulation by Probiotics Administration as Emerging Tool in Cancer Prevention and Therapy
por: Panebianco, Concetta, et al.
Publicado: (2020)

Co-Development of Diagnostic Vectors to Support Targeted Therapies and Theranostics: Essential Tools in Personalized Cancer Therapy
por: Nicolaides, Nicholas C., et al.
Publicado: (2014)

Glucocorticoid receptor and androgen receptor-targeting therapy in patients with castration-resistant prostate cancer
por: Pak, Sahyun, et al.
Publicado: (2022)

Single Cell Functional Proteomics for Assessing Immune Response in Cancer Therapy: Technology, Methods, and Applications
por: Ma, Chao, et al.
Publicado: (2013)

Protons, Photons, and the Prostate – Is There Emerging Evidence in the Ongoing Discussion on Particle Therapy for the Treatment of Prostate Cancer?
por: Schiller, Kilian C., et al.
Publicado: (2016)

Targeting the Extra-Cellular Matrix—Tumor Cell Crosstalk for Anti-Cancer Therapy: Emerging Alternatives to Integrin Inhibitors
por: Lorusso, Girieca, et al.
Publicado: (2020)

Chimeric antigen receptor T-cell therapy for T-ALL and AML
por: Wei, Wenwen, et al.
Publicado: (2022)

Expanding Roles for CD4 T Cells and Their Subpopulations in Tumor Immunity and Therapy
por: Dobrzanski, Mark J.
Publicado: (2013)

A Comprehensive Analysis of Key Immune Checkpoint Receptors on Tumor-Infiltrating T Cells From Multiple Types of Cancer
por: Li, Xi, et al.
Publicado: (2019)

Editorial: Cancer Plasticity and the Microenvironment: Implications for Immunity and Therapy Response
por: Behren, Andreas, et al.
Publicado: (2019)

Relevance of Fc Gamma Receptor Polymorphisms in Cancer Therapy With Monoclonal Antibodies
por: Mata-Molanes, Juan J., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_me3g28d0eiai7vpfe62nvqed8p